Form 4: 10x Genomics Executive Sells Shares to Cover Tax Obligations

Benjamin J. Hindson, President and Chief Scientific Officer of 10x Genomics, sold 5,807 shares of Class A Common Stock to cover tax obligations related to vesting restricted stock units.

Summary

• Benjamin J. Hindson, President and Chief Scientific Officer at 10x Genomics, sold 5,807 shares of Class A Common Stock on November 22, 2024.
• The sale was executed at a price of $13.6878 per share.
• The transaction was to cover tax withholding obligations associated with the vesting of restricted stock units.
• Following the transaction, Hindson directly owns 339,897 shares of Class A Common Stock.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction for tax purposes, not indicative of positive or negative sentiment.

Management Comments

• The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units.

Industry Context

Executive stock sales are a common occurrence, particularly around vesting events. This transaction is not unusual and is likely a routine part of executive compensation.

Comparison to Industry Standards

• Executive stock sales to cover tax obligations are a standard practice across publicly traded companies.
• Similar transactions are regularly reported by executives at comparable biotech and life sciences companies.

Stakeholder Impact

• The transaction is unlikely to have a significant impact on shareholders, as it is a routine sale for tax purposes.

Key Dates

Keywords

10x Genomics, insider trading, stock sale, executive, tax obligations, restricted stock units, TXG, Benjamin J. Hindson